Scientific advisory on nocturnal hypoglycemia in insulin-treated patients with diabetes: Recommendations from Indian experts.

Autor: Chawla M; Lina Diabetes Care Centre, Mumbai, India. Electronic address: linadiabetes@gmail.com., Chawla P; Consultant Diabetologist and Director of Clinical Research, Lina Diabetes Care and Mumbai Diabetes Research Centre, Mumbai, India., Saboo B; Dept of Endocrinology, Dia Care, Ahmedabad, Gujrat, India., Chawla R; North Delhi Diabetes Centre, Rohini, New Delhi, India., Gangopadhyay KK; Consultant in Endocrinology, CK Birla Hospitals, Peerless Hospital, India., Kalra S; Department of Endocrinology, Bharti Hospital, Karnal, India., Aravind S; Diacon Hospital, Bangalore, India., Sinha B; AMRI and Fortis Hospitals, Kolkata, India., Shah T; Director and Diabetologist Iva Diabetes Care Centre Mumbai, Sl Raheja Fortis Hospital, Mumbai, India., Kesavadev J; Jothydev's Diabetes and Research Center, Kerala, India., Rajput R; Department of Endocrinology, PGIMS, Rohtak, Haryana, India.
Jazyk: angličtina
Zdroj: Diabetes & metabolic syndrome [Diabetes Metab Syndr] 2022 Sep; Vol. 16 (9), pp. 102587. Date of Electronic Publication: 2022 Aug 23.
DOI: 10.1016/j.dsx.2022.102587
Abstrakt: Introduction: Insulin is one of the commonly prescribed glucose lowering agents in diabetes. Hypoglycemia is the most common complication, and severe hypoglycemia is the most serious complication of insulin therapy. Almost half of all severe hypoglycemia episodes (HEs) occur at night. However, patients are often unaware of their nocturnal hypoglycaemia (NH) risk. Additionally, both healthcare professionals and patients find it difficult to manage NH. The purpose of this expert group meeting is to improve NH awareness and provide guidance for the physicians to recognize and manage NH.
Method: The panel of experts in an e-board deliberated extensively upon the available literature and guidelines on hypoglycemia and NH discussed the consensus on definition, detection, reporting, monitoring, treatment, and optimization of therapy in NH.
Result: & Conclusion: Though there are many guidelines on the management of HEs in patients with diabetes, very few touch the topic of NH. This scientific advisory on management of NH in insulin treated patients with diabetes is formulated to address this gap in understanding regarding management of NH. The experts provide recommendations for the nocturnal window, defining NH based on blood glucose values, recognition, prevention and management of NH.
Competing Interests: Declaration of competing interest None.
(Copyright © 2022. Published by Elsevier Ltd.)
Databáze: MEDLINE
Externí odkaz: